Eli Lilly exec expects obesity pill data in April 2025

Data from Eli Lilly's late
stage trial on experimental obesity pill orforglipron is
expected in April 2025, a top Eli Lilly executive said
on Monday.
The pill is part of a class of drugs...

Related Keywords

Eli Lilly ,Patrik Jonsson ,Sandra Maler ,Goldman Sachs ,Reuters ,Lilly Diabetes ,Michael Erman ,